Though medical research has not definitively established which biomarkers accurately predict Alzheimer's disease, the National Institute on Aging and the Alzheimer's Association are issuing new guidelines today that include an early stage where no dementia symptoms are present but brain changes have begun. The new guidelines reflect the desire for early diagnosis and prevention.
Rep. Market of Massachusetts has introduced a bill in Congress to establish specific billing codes for steps in Alzheimer's diagnosis to encourage early diagnosis and treatment.
For more information see this article in today's New York Times www.nytimes.com/2011/04/19/health/19alzheimer.html?_r=1&hp
No comments:
Post a Comment